SCHEMBL2201976

SCHEMBL2201976

C[N+](C)(C)CC(CC(=O)[O-])OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
CYP1A2 P05177 2/20 0.50
HRH1 P35367 1/20 0.50
CYP2C19 P33261 3/20 0.48
RECQL P46063 1/20 0.48
ALPL P05186 1/20 0.43
POLB P06746 1/20 0.43
ALPG P10696 1/20 0.43
SLC22A16 Q86VW1 1/20 0.42
SLC25A20 O43772 3/20 0.42
CYP2D6 P10635 3/20 0.42
TSHR P16473 3/20 0.42
TP53 P04637 2/20 0.42
CYP2C9 P11712 2/20 0.42
SLC6A5 Q9Y345 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
NFKB1 P19838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9634318 1.00 MEN1 (0.50) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL17303194 0.95 MEN1 (0.46) MEN1KMT2ACYP1A2HRH1CYP2C19
Perchlorate SCHEMBL9634002 0.95 MEN1 (0.46) MEN1KMT2ACYP1A2HRH1CYP2C19
Perchlorate SCHEMBL9633990 0.95 MEN1 (0.46) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL28314908 0.88 LMNA (0.49) MEN1KMT2ACYP1A2CYP2C19CYP2D6
SCHEMBL8184237 0.85 MEN1 (0.47) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL2308345 0.84 KMT2A (0.43) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL2995885 0.83 LMNA (0.44) MEN1KMT2ACYP1A2CYP2C19CYP2D6
SCHEMBL9574228 0.81 LMNA (0.42) MEN1KMT2ACYP1A2CYP2C19CYP2D6
SCHEMBL9625918 0.80 MEN1 (0.60) MEN1KMT2ACYP1A2HRH1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230346735-A1 Nutritional Composition Comprising Carnitine and Method for Treating or Preventing an Infection in a Mammal LONZA GREENWOOD LLC 2023-11-02 US claimed
EP-4125858-A1 NUTRITIONAL COMPOSITION COMPRISING CARNITINE AND METHOD FOR TREATING OR PREVENTING AN INFECTION IN A MAMMAL Lonza Consumer Health Inc. (US) 2023-02-08 EP claimed
WO-2021221741-A1 NUTRITIONAL COMPOSITION COMPRISING CARNITINE AND METHOD FOR TREATING OR PREVENTING AN INFECTION IN A MAMMAL LONZA CONSUMER HEALTH INC. (US) 2021-11-04 WO claimed
CN-107519496-B L-carnitine amphiphilic derivative, nanoparticle modified by same and application thereof SHENYANG PHARMACEUTICAL UNIVERSITY (CN) 2019-12-10 CN claimed
CN-107519496-A A kind of L carnitines amphipathic derivatives and its nanoparticle of modification and application thereof 沈阳药科大学 2017-12-29 CN claimed
EP-0252030-B1 DERIVATIVES OF L-AMINO ACYL L-CARNITINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS HAVING HEPATOPROTECTING ACTIVITY CONTAINING SAME Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1992-06-17 EP claimed
EP-0446185-A1 Alpha-amino-omega-alkylthioacylcarnitines active on the cardiovascular system and pharmaceutical compositions containing same SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. (IT) 1991-09-11 EP claimed
US-4812478-A Derivatives of L-amino acyl L-carnitine, process for their preparation and pharmaceutical compositions having hepatoprotecting activity containing same SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1989-03-14 US claimed
EP-0252030-A2 Derivatives of L-amino acyl L-carnitine, process for their preparation and pharmaceutical compositions having hepatoprotecting activity containing same Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1988-01-07 EP claimed
EP-4125858-B1 NUTRITIONAL COMPOSITION COMPRISING L-CARNITINE TARTRATE FOR USE IN TREATING OR PREVENTING A CORONAVIRUS INFECTION IN A MAMMAL LONZA GREENWOOD LLC (US) 2026-05-06 EP disclosed
US-20230346735-A1 Nutritional Composition Comprising Carnitine and Method for Treating or Preventing an Infection in a Mammal LONZA GREENWOOD LLC 2023-11-02 US disclosed
US-11785966-B2 Use of gamma-quaternary ammonium butyrate compound in preparation of an animal feed additive Anipha Technologies Pty Ltd (AU) 2023-10-17 US disclosed
EP-3154539-B1 METHOD FOR DECREASING SKELETAL MUSCLE DAMAGE AND/OR OXIDATIVE STRESS IN MAMMALS LONZA CONSUMER HEALTH INC (US) 2023-03-22 EP disclosed
EP-4125858-A1 NUTRITIONAL COMPOSITION COMPRISING CARNITINE AND METHOD FOR TREATING OR PREVENTING AN INFECTION IN A MAMMAL Lonza Consumer Health Inc. (US) 2023-02-08 EP disclosed
WO-2008018877-A1 CARNITINE CONJUGATES AS DUAL PRODRUGS, METHODS OF PRODUCTION AND USES THEREOF SSV THERAPEUTICS, INC. (US) 2008-02-14 WO disclosed
WO-2007117544-A2 CARNITINE CONJUGATES OF ADAMANTANAMINES AND NERAMEXANE DERIVATIVES AS DUEL PRODRUGS FOR VARIOUS USES SSV THERAPEUTICS, INC. (US) 2007-10-18 WO disclosed
EP-0252030-B1 DERIVATIVES OF L-AMINO ACYL L-CARNITINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS HAVING HEPATOPROTECTING ACTIVITY CONTAINING SAME Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1992-06-17 EP disclosed
US-4868211-A LIVER DISORDERS 501 SIGMA TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1989-09-19 US disclosed
US-4812478-A Derivatives of L-amino acyl L-carnitine, process for their preparation and pharmaceutical compositions having hepatoprotecting activity containing same SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1989-03-14 US disclosed
EP-0252030-A2 Derivatives of L-amino acyl L-carnitine, process for their preparation and pharmaceutical compositions having hepatoprotecting activity containing same Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1988-01-07 EP disclosed